Sharda Cropchem Ltd
Sharda Cropchem Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Expected volume growth of around 15% in FY '27. The company expects volume growth of around 15% for FY '27.
From Sharda Cropchem Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Expected volume growth of around 15% in FY '27.
- Revenue growth anticipated between 15% to 20% in FY '27.
- Q4 FY '26 projected as the strongest quarter with demand growth continuing.
- Growth driven by both new dealers and expanded geographic reach, especially in Europe.
- Price levels expected to improve gradually, supporting better margins.
- Strong pipeline with 1,076 product registrations in approval, supporting sustained future growth.
- Continued focus on increasing registrations and market penetration within key regions (Europe, NAFTA, LATAM).
- Capex planned in the range of INR 450-500 crores to support growth and registration activities.
Profitability & Margins
See what Sharda Cropchem Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned capital expenditure (capex) for FY '26 is around INR 500 crores, with INR 399 crores already spent in the first 9 months.
- Capex is aimed at supporting a strong project pipeline, focusing on growth and resilience.
- For FY '27, capex guidance is estimated to be in the range of INR 450 crores to INR 500 crores, though it could be higher due to uncertainties.
- The capex primarily supports increasing the global registration pipeline of approximately 1,070 products.
- Registration timelines are uncertain and can vary widely from 1 year to up to 6-7 years.
- The company is not currently looking at acquisitions but is considering increasing dividend payouts instead.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sharda Cropchem Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- As of December 31, 2025, Sharda Cropchem's total product registrations stand at 3,004 globally.
- There are 1,076 product registration applications currently in the approval pipeline.
- Regional breakup of pending registrations: Europe - 698, NAFTA - 100, LATAM - 153, Rest of the World - 125.
- Registration process timelines are uncertain; can range from 1-2 years to even 6-7 years due to regulatory complexities.
- The company is investing around INR 400-500 crores capex towards expanding registration pipeline and related capacities.
- These registrations form a critical part of their order book for future revenue growth and market expansion.
Sharda Cropchem Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹319 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sharda Cropchem Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Indogulf Cropsciences Ltd (Q3 FY26)
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…
- Rallis India Ltd (Q3 FY26)
Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness. Key concall takeaways from Rallis India's Q3 FY26…
- Krishana Phoschem Ltd (Q3 FY26)
It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Key concall takeaways from Krishana…
- Paradeep Phosphates Ltd (Q3 FY26)
Sustainable EBITDA per ton likely to improve by 30-35% once all sites achieve 100% backward integration (Page 13). Key concall takeaways from Paradeep…
Frequently Asked Questions
What were Sharda Cropchem Ltd Q3 FY26 results?
Expected volume growth of around 15% in FY '27. The company expects volume growth of around 15% for FY '27.
What is Sharda Cropchem Ltd share price analysis?
Sharda Cropchem Ltd currently shows a neutral. The stock trades at a P/E of 11.3 with a market cap of ₹7,095 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sharda Cropchem Ltd planning capital expenditure?
Planned capital expenditure (capex) for FY '26 is around INR 500 crores, with INR 399 crores already spent in the first 9 months.
Keep Sharda Cropchem Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.